Pennsylvania Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 31 (72% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 9,396
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 45.95%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 994
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 30.33%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 47.34% 63.08%
White, Hispanic/Latino Patients 9.07% 5.73%
Black/African American, Non-Hispanic/Latino Patients 17.49% 13.18%
Black/African American, Hispanic/Latino Patients 1.35% 1.01%
Asian Patients3 2.69% 1.71%
American Indian/Alaska Native Patients3 0.28% 0.20%
Native Hawaiian/Other Pacific Islander Patients3 0.30% 0.10%
Patients with More than one race3 1.30% 0.91%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 7.78% 4.63%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 8.84% 5.73%
Unreported/Refused to Report Race and Ethnicity 3.57% 3.72%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,827
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 73.64%
COVID-19 Immunization Series Completed 1,815
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 76.89%
COVID-19 Immunization Series Additional 306
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 49.80%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 22.88% 18.73% 41.50%
White, Hispanic/Latino Patients 13.41% 18.13% 7.84%
Black/African American, Non-Hispanic/Latino Patients 28.41% 22.81% 16.01%
Black/African American, Hispanic/Latino Patients 2.24% 1.71% 1.63%
Asian Patients3 2.19% 2.70% 4.25%
American Indian/Alaska Native Patients3 0.49% 0.22% 4.25%
Native Hawaiian/Other Pacific Islander Patients3 1.31% 1.32% 0.65%
Patients with More than one race3 3.07% 2.64% 3.27%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 12.81% 12.78% 3.27%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.12% 9.20% 4.25%
Unreported/Refused to Report Race and Ethnicity 10.07% 9.75% 13.07%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 12.90%
1 to 24 Hours 12.90%
More Than 24 Hours 74.19%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 12.90%
Staffing to administer the vaccine 35.48%
Vaccine confidence 32.26%
Vaccine storage capacity 9.68%
Vaccine supply 3.23%
Other 9.68%
None 29.03%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 3.23%
Average Percent of Health Center Visits Conducted Virtually 20.97%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 58.06%
Number of Mobile Van Sites 21
Number of Pop-up Clinics 31
Number of School-Based Vaccination Sites 2

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 6.45%
Refer patients to another organization that provides monoclonal antibody therapies 48.39%
None 45.16%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 12.90%
Patient awareness/education 9.68%
Staffing capacity 22.58%
Therapy administration/onsite logistics 12.90%
Other 9.68%
None 54.84%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021